insights from industry Yavuz Çelik Global Product Manager Hamilton Bonaduz AG In this interview, News Medical speaks with ...

This is a preview. Log in through your library . Abstract A procedure for following changes in the steady-state yield of chlorophyll a fluorescence (Fs) from single guard cell pairs in variegated ...

Abcam is a global life sciences company providing highly validated antibodies and other binders and assays to the research and clinical communities to help advance the understanding of biology and ...

Molecular gradients have been established as a key driving force for cellular organization in the formation of early structures during embryonic development. A new live imaging technique has been ...

Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan–Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer ...

UNO therapy results in a more immunogenic tumor microenvironment (TME) as well as a systemic response that overcomes anti-PD-1 resistance First-in-human Phase 1 clinical study is ongoing with initial ...

Topline results from the RISE UP phase 3 trial demonstrated that mitapivat significantly improved hemoglobin response in patients with sickle cell disease.